首页> 外文OA文献 >22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS

【2h】

22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS

机译：22. ALK抑制剂在ALK抑制剂 - 幼稚ALK +肺癌脑转移中的比较疗效：网络元分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Philip Haddad; Dalia Hammoud; Kevin Gallagher;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P2.03b-018 Clinical Data from the Real World: Efficacy of Crizotinib in Chinese Patients with Advanced ALK+ Non-Small Cell Lung Cancer and Brain Metastases [J] . Shouzheng Wang, Puyuan Xing, Junling Li, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：来自现实世界的P2.03B-018临床资料：屈服尼在中国高级ALK +非小细胞肺癌和脑转移患者中的疗效
2. P2.03b-018 Clinical Data from the Real World: Efficacy of Crizotinib in Chinese Patients with Advanced ALK+ Non-Small Cell Lung Cancer and Brain Metastases [J] . Shouzheng Wang, Puyuan Xing, Junling Li, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：来自现实世界的P2.03B-018临床资料：屈服尼在中国高级ALK +非小细胞肺癌和脑转移患者中的疗效
3. Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases [J] . Gettinger S. N., Bazhenova L., Salgia R., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2015,第Suppla1期

机译：AP26113在ALK +非小细胞肺癌（NSCLC）中（包括脑转移患者）的疗效和安全性
4. Topological, Functional, and Structural Analyses of Protein-protein Interaction Networks of Breast Cancer Lung and Brain Metastases [C] . Farideh Halakou, Attila Gursoy, Emel Sen Kilic, IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology . 2017

机译：乳腺癌肺和脑转移蛋白质 - 蛋白质互动网络的拓扑，功能和结构分析
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. 22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS [O] . Philip Haddad, Dalia Hammoud, Kevin Gallagher 2020

机译：22. ALK抑制剂在ALK抑制剂 - 幼稚ALK +肺癌脑转移中的比较疗效：网络元分析
7. BMET-13. WHOLE BODY AND INTRACRANIAL EFFICACY OF CERITINIB IN ALK-INHIBITOR (ALKi)-NAIVE PATIENTS WITH ALK-REARRANGED (ALK+) NSCLC AND BASELINE BRAIN METASTASES (BM): RESULTS FROM ASCEND-1 AND -3 [O] . Ranee Mehra, Enriqueta Felip, Daniel Shao-Weng Tan, 2016

机译：BMET-13。 Ceritinib在ALK抑制剂（ALKI）中的全身和颅内疗效 - 患有ALK重新排列（ALK +）NSCLC和基线脑转移（BM）的患者：Ascend-1和-3的结果

22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS

著录项

引文网络

相似文献

相关主题

期刊订阅